| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.07 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.07 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |